Asia-Pacific Long-Acting Bronchodilator Market Size | COVID-19 Impact Analysis | Forecast to 2025
Asia-Pacific long-acting bronchodilator market is anticipated to grow at a substantial rate of 4.5% during the forecast period. Major factors that augment the growth of the market include a large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and the significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by major pharmaceutical companies in pharma and life science research coupled with harnessing innovation. The long-acting bronchodilator market in the Asia-Pacific region presents future opportunities for growth as the prevalence of respiratory diseases such as asthma, COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market.
To Request a Sample of our Report on Asia-Pacific
Long-Acting Bronchodilator Market: https://www.omrglobal.com/request-sample/asia-pacific-long-acting-bronchodilator-market
Asia-Pacific long-acting
bronchodilator market is segmented on the basis of route of administration,
application, and end-user. Based on the route of administration, the market is
classified into oral, nasal, parenteral, and inhalation. Moreover, on the basis
of application, the market has been classified into asthma and COPD diseases.
The asthma disease application segment dominated the regional market in 2018
and is further estimated to follow the same trend over the forecast period.
This is mainly due to the increasing pool of aging population susceptible to
the high prevalence of asthma in the economies of the region such as China and
India.
(Get 15% Discount on Buying this Report)
A
full Report of Asia-Pacific Long-Acting Bronchodilator Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-long-acting-bronchodilator-market
Asia-Pacific Long-Acting Bronchodilator Market Segmentation
By Route of Administration
·
Oral
·
Nasal
·
Parenteral
·
Inhalation
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Regional
Analysis
·
China
·
Japan
·
India
Rest of Asia-Pacific
Company Profiles
·
Adamis Pharmaceuticals Corp.
·
AstraZeneca PLC
·
Boehringer Ingelheim International GmbH
·
GlaxoSmithKline PLC
·
Novartis AG
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Sunovion Pharmaceuticals
·
Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment